A PRIME-BOOST VACCINATION STRATEGY IN CATTLE TO PREVENT SEROTYPE O FMDV INFECTION USING A “SINGLE-CYCLE” ALPHAVIRUS VECTOR AND EMPTY CAPSID PARTICLES Maria.

Slides:



Advertisements
Similar presentations
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Advertisements

Hybrid SFV VRP system Eva Žusinaite, MD, PhD Tartu University Institute of Technology Estonia VIII Annual Conference of New Visby Network on Hepatitis.
Chapter 12-Vaccines Traditional vs. rDNA vaccines Subunit vaccines Peptide vaccines Genetic immunization: DNA vaccines Attenuated vaccines Vector vaccines.
Prof. Fatma Amer Medical Microbiology and Immunology, ZAGAZIG FACULTY OF Medicine, Egypt President of ISC/HWG President of ArAPUA In the Era of Direct.
Acquired Immunity.
Vaccines Polio - close to eradication. In 2001 >1000 cases worldwide; last wild case in Americas in Peru in 1991.
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Dr Hannah Kibuuka Makerere University Walter Reed Project Presentation at the Uganda Medical Association-Uganda Veterinary Association joint conference.
Phagocyte. B cells Receptor B Cell Naïve B cell B cells and antibodies daughter cells produce antibodies phagocyte consumes an antibody coated virus.
Recent information about alternative vaccination schedules to control (first step before eradication) PRRS in pig farm.
Viral Vaccine Types Viruses are inactivated with chemicals such as formaldehyde. Inactivated (killed) vaccines cannot cause an infection, but they.
Immunogenicity of combined vaccines in infants Helena Käyhty, PhD National Public Health Institute Dept of Vaccines Helsinki, Finland.
Generation of mAbs to FMDV/A and application in a cELISA for the detection of FMDV/A antibodies Dr. M. Yang National Center for Foreign Animal diseases.
Hepatitis Virus. Primary members HAV HBV HCV HDV HEV.
Improved prediction of antigenic relationships among RNA viruses Richard Reeve Boyd Orr Centre for Population and Ecosystem Health University of Glasgow.
Bernd Haas 14 March 1958 – 4 October Replacement of FMDV cattle tongue titration by in-vitro titration Aldo Dekker.
DECEPTIVE IMPRINTING OF FMDV: MAPPING OF CAPSID HYPER-VARIABLE REGIONS BETWEEN TWO DISPARATE SAT2 STRAINS Tovhowani Ramulongo Lia Rotherham, Pamela Opperman,
Julian Seago Improving quality assurance of FMD vaccine production.
14. Immunodiagnosis, Immunotherapy & Vaccination 王 家 鑫, MD College of Veterinary Medicine.
Enhanced Protection with Inactivated Foot-and-Mouth Disease Virus Purified by a Tagged-Marker Expressing on Virus Surface Animal and Plant Quarantine Agency.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
اختبارات التعادل المناعي:Neutralization Tests:
Virus vaccines LECTURE 18: Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology Waqas Nasir Chaudhry.
Recombinant Hormones and Drugs.  Many human disorders traced to absence or malfunction of a protein normally synthesized in the body  eg. Sickle cell.
Vaccine; To be effective  Must stimulate as many of the body's defence mechanisms as possible.  It is not necessary to get 100% uptake of vaccine in.
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Chapter 12-Vaccines Traditional vs. rDNA vaccines Subunit vaccines
11 – Animal Physiology (HL) 11.1 – Antibody Production and Vaccination
Virus Basics - part I Viruses are genetic parasites that are smaller than living cells. They are much more complex than molecules, but clearly not alive,
Immunogenicity of poliovirus non-structural proteins during natural poliovirus infection. Maria Prostova1, Maria Yakovenko1, Tatyana Eremeeva1, Olga Baykova1,
PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES OF TYPE O FOOT AND MOUTH DISEASE STRAINS ISOLATED FROM SOUTH AMERICAN OUTBREAKS (2006 TO 2011) Galdo Novo S1,
Molecular Therapy - Methods & Clinical Development
Chapter 7-Vaccines Vaccination Current and future vaccines
A flavone-based inhibitor of in vitro human rhinovirus replication induces resistant mutations in capsid protein VP4. Céline Lacroixa, Hari Babu Bollikollac,
RESULTS AND DISCUSSION
DISCUSSION AND CONCLUSION
Autophagy reduces Semliki Forest virus replication in neuronal cells
Which part?.
Vaccination -Several weeks are required before the immune system develops immunity to a new antigen -To overcome this problem, vaccinations safely give.
Efficacy of a Foot-and-Mouth Disease inactivated vaccine (AFTOVAXPUR DOE), administered at a 1 mL dose to sheep Claude Hamers.
The Lymphatic System.
Novel vaccine adjuvants for infectious diseases aninal
Novel Technique for Early Detection of Pancreatic Cancer
Viruses.
APPLICATION OF INDIRECT AND AVIDITY ELISAs TO ASSESS ANTI-FMDV ANTIBODIES INDUCED BY VACCINATION IN BUFFALO AND SWINE SERUM SAMPLES F. Mansilla,; J. Sala,
Demonstration of early protection against foot-and-mouth disease virus
No heterologous protection with SAT2 SAU
I will be able to define the following terms:
DEVELOPMENT OF A NOVEL VNT ASSAY USING QRT-PCR-BASED ENDPOINT ASSESSMENT FOR RAPID DETECTION AND TITRATION OF NEUTRALIZING ANTIBODIES AGAINST FMDV.
Vaccine Differentiation Group
SELECTION OF AN ADJUVANT TO RAISE POLYCLONAL ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS IN RABBITS AND GUINEA-PIGS Alison Morris | Beatriz Sanz-Bernardo.
Characterization of FMDV isolates from Sudan collected from outbreaks
Antibodies.
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1  Richard Brans,
Nucleotide sequences encoding part of the VP1 capsid protein of FMDVs derived from infected cattle in phase I and phase II of the study. Nucleotide sequences.
Immune responses to foot-and-mouth disease virus in guinea pigs after vaccination with canine adenovirus vector S.A. Lacour, A. De Vleeschauwer, L. Bakkali-Kassimi,
Department of Biotechnology University of Malakand
Volume 26, Issue 2, Pages (February 2018)
FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.
A brief discussion on passive and active (esp., vaccines) immunity
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Week 15 Vocab Definitions
US Army Medical Research and Materiel Command
Will There Be a Vaccine to Protect Against the Hepatitis C Virus?
Volume 25, Issue 12, Pages e3 (December 2018)
Challenges, Consideration, and Progress
Pulmonary vaccination induces a long-term immune memory response to antigen challenge. Pulmonary vaccination induces a long-term immune memory response.
Viruses and Vaccines And Antibodies.
VACCINATION. Vaccination: Is The administration of an antigen to stimulate a protective immune response against an infectious agent.
Identification of the recombinant structural proteins expressed in recombinant baculovirus-infected Sf9 cells by immunofluorescence assay with rabbit anti-FMDV.
Presentation transcript:

A PRIME-BOOST VACCINATION STRATEGY IN CATTLE TO PREVENT SEROTYPE O FMDV INFECTION USING A “SINGLE-CYCLE” ALPHAVIRUS VECTOR AND EMPTY CAPSID PARTICLES Maria Gullberg1, Louise Lohse1, Anette Bøtner1, Gerald M. McInerney2, Alison Burman3, Terry Jackson3, Charlotta Polacek1 and Graham J. Belsham1 1DTU National Veterinary Institute, Technical University of Denmark, Lindholm, Kalvehave, Denmark 2Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. 3The Pirbright Institute, Pirbright, Woking, Surrey, U.K

Summary ●Single cycle alphavirus vector (rSFV-FMDV) expresses FMDV empty capsid particles ● Single vaccination of cattle with rSFV-FMDV induces anti-FMDV antibodies but not protection ● Vaccination with rSFV-FMDV primes an anti-FMDV immune response ● Vaccination with rSFV-FMDV followed by empty capsids induces protection ● No viremia observed post-challenge in cattle

Why recombinant FMDV vaccines? Challenge: Current FMDV vaccines are not optimal Chemically inactivated virus has to be grown under high containment Short duration of immunity Aim: Develop an improved, safe, vaccine based on expression of self-assembling empty capsid particles within cells - No serotype cross protection - Short vaccine protection time - Vaccine stability - Airborne - Some animal species high shedders, poor indicator animals 2 "New FMDV vaccine approach" (aims: ... etc. as in this slide) 3

FMDV particle formation 3B1-3 Lab VP4 2A Lb VP2 VP3 VP1 2B 2C 3A 3C 3D FMDV VP0 (Empty capsid particle proteins) VP0 VP3 VP1 Encapsidation of RNA (Virus particle proteins) VP4 VP2 VP3 VP1 Empty capsid particle Virus particle Belsham & Bøtner, 2015

rSFV-FMDV design FMDV cDNA SFV vector

SFV split helper system Vaccine Expression of foreign protein Smerdou and Liljeström, 1999 6

Expression of FMDV capsid proteins by rSFV-FMDV vectors Antigen ELISA WB Abs 450nm Sucrose gradient Gullberg et al., 2016

Single inoculation of cattle with rSFV-FMDV vectors and FMDV challenge Ab ELISA Temperature Viremia Outcome Control FMD rSFV-P1-2A FMD rSFV-P1-2A-mIRES3C FMD

Anti-FMDV antibody titres (ELISA) Group Animal PVD 14 PVD 21 PVD 27 PVD 30 1 Control C1 - 20 1 C2 2 rSFV-P1-2A C3 320 2 C4 C5 5 >640 3 rSFV-P1-2A-mIRES-3C C6 10 3 C7 C8 Low titre anti-FMDV response induced by rSFV-FMDV alone. Much stronger anti-FMDV response post challenge (on PVD 21) in rSFV-FMDV inoculated animals Gullberg et al., 2016

Prime-boost strategy Use of: 1) rSFV-P1-2A-mIRES-3C 2) Purified ”empty capsid” (EC) particles (expressed from vaccinia virus vectors, Porta et al., 2013). Plan (3 groups) 1) Control (no inoculation) 2) Inoculate with rSFV-P1-2A-mIRES-3C (PVD 0), then boost with ECs (on PVD 14) 3) Inoculate with ECs (PVD 0), then boost with rSFV-P1-2A-mIRES-3C (on PVD 14) Challenge with FMDV on PVD 28

Protection against FMDV challenge FMDV RNA Temperature Control FMD rSFV + ECs No disease ECs + rSFV FMD Gullberg et al., 2016

Anti-FMDV responses in cattle Ab ELISA VNT titre VNT titres Pre-boost Control Pre-challenge rSFV + EC EC + rSFV Post-challenge Gullberg et al., 2016

Conclusions rSFV-FMDV vectors can express FMDV empty capsids in cells Single inoculation with rSFV-FMDVs induces low titre anti-FMDV responses BUT primes antibody induction Prime-boost strategy using rSFV-FMDV vector followed by ECs generates strong anti-FMDV response that blocks FMDV dissemination in cattle following challenge The prime-boost strategy using rSFV-FMDV vectors and ECs has properties at least as good as current vaccine and can be made outside of high containment Duration of immunity, minimum dose required etc. … to be determined